FI902880A0 - Polypeptider och polypeptidanaloger. - Google Patents

Polypeptider och polypeptidanaloger.

Info

Publication number: FI902880A0
Authority: FI; Finland
Prior art keywords: pro; cys; lys; gly; ile
Prior art date: 1989-06-09

Application number

FI902880A

Other languages

English (en)

Other versions

FI106471B (fi

Inventor

Enno Christophers

Oliver Wiedow

Jens-Michael Schroder

Michael Derek Edge

David Pioli

Original Assignee

Ici Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-09

Filing date

1990-06-08

Publication date

1990-06-08

1989-06-09 Priority claimed from GB898913346A external-priority patent/GB8913346D0/en

1989-06-09 Priority claimed from GB898913349A external-priority patent/GB8913349D0/en

1989-09-25 Priority claimed from GB898921613A external-priority patent/GB8921613D0/en

1989-11-02 Priority claimed from GB898924717A external-priority patent/GB8924717D0/en

1990-06-08 Application filed by Ici Plc filed Critical Ici Plc

1990-06-08 Publication of FI902880A0 publication Critical patent/FI902880A0/fi

2001-02-15 Application granted granted Critical

2001-02-15 Publication of FI106471B publication Critical patent/FI106471B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Mycology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Immunology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

FI902880A 1989-06-09 1990-06-08 Menetelmä polypeptidien valmistamiseksi, polypeptidejä koodaava DNA-sekvenssi, ilmentämisvektori ja isäntäsolu FI106471B (fi)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
GB898913346A GB8913346D0 (en)	1989-06-09	1989-06-09	Polypeptide analogues
GB898913349A GB8913349D0 (en)	1989-06-09	1989-06-09	Polypeptides
GB8913346		1989-06-09
GB8913349		1989-06-09
GB8921613		1989-09-25
GB898921613A GB8921613D0 (en)	1989-09-25	1989-09-25	Polypeptides-1st update
GB898924717A GB8924717D0 (en)	1989-11-02	1989-11-02	Polypeptides
GB8924717		1989-11-02

Publications (2)

Publication Number	Publication Date
FI902880A0 true FI902880A0 (fi)	1990-06-08
FI106471B FI106471B (fi)	2001-02-15

Family

ID=27450350

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI902880A FI106471B (fi)	1989-06-09	1990-06-08	Menetelmä polypeptidien valmistamiseksi, polypeptidejä koodaava DNA-sekvenssi, ilmentämisvektori ja isäntäsolu

Country Status (16)

Country	Link
US (4)	US5464822A (fi)
EP (1)	EP0402068B1 (fi)
JP (1)	JP2989853B2 (fi)
AT (1)	ATE131493T1 (fi)
AU (1)	AU636148B2 (fi)
CA (1)	CA2018592C (fi)
DE (1)	DE69024104T2 (fi)
DK (1)	DK0402068T3 (fi)
ES (1)	ES2080800T3 (fi)
FI (1)	FI106471B (fi)
GR (1)	GR3018401T3 (fi)
IE (1)	IE70520B1 (fi)
IL (1)	IL94602A (fi)
NO (1)	NO177716C (fi)
NZ (1)	NZ233974A (fi)
PT (1)	PT94326B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO177716C (no) *	1989-06-09	1995-11-08	Zeneca Ltd	Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
EP0458537B1 (en) *	1990-05-24	1999-03-31	Zeneca Limited	Use of a therapeutic compound for the treatment of bronchitis
DE69129083T2 (de) *	1990-05-24	1998-07-09	Zeneca Ltd	Therapeutisches Mittel zur Vorbeugung und Behandlung des Atemnotsyndroms bei Erwachsenen
US5162348A (en) *	1990-05-24	1992-11-10	Imperial Chemical Industries Plc	Treatment of cystic fibrosis
US5734014A (en) *	1992-08-11	1998-03-31	Tsumura & Co.	Elafin derivative
US5835061A (en) *	1995-06-06	1998-11-10	Wayport, Inc.	Method and apparatus for geographic-based communications service
US8606851B2 (en)	1995-06-06	2013-12-10	Wayport, Inc.	Method and apparatus for geographic-based communications service
EP0834556A1 (en) *	1996-09-25	1998-04-08	Academisch Ziekenhuis Leiden	Methods for culturing cells
US7034132B2 (en)	2001-06-04	2006-04-25	Anderson David W	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2001241913A1 (en) *	2000-03-01	2001-09-12	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods for wound treatment
US7247704B2 (en) *	2000-12-18	2007-07-24	Arriva Pharmaceuticals, Inc.	Multifunctional protease inhibitors and their use in treatment of disease
US6600057B2 (en)	2000-12-29	2003-07-29	Kimberly-Clark Worldwide, Inc.	Matrix metalloproteinase inhibitors
US7041787B2 (en) *	2000-12-29	2006-05-09	Kimberly-Clark Worldwide, Inc.	Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
US20030119073A1 (en) *	2001-12-21	2003-06-26	Stephen Quirk	Sensors and methods of detection for proteinase enzymes
EP2902501B1 (en)	2002-01-28	2020-04-15	Life Technologies Corporation	Preparing crude biological extracts using protease, suitable for preparing cDNA
CA2483102C (en) *	2002-04-25	2013-06-18	The Scripps Research Institute	Treatment and prevention of pulmonary conditions
FR2849375B1 (fr) *	2002-12-30	2006-10-20	Jean Noel Thorel	Compositions cosmetiques, par exemple pour traiter le vieillissement cutane photo-induit
CA2524626A1 (en) *	2003-05-07	2004-11-18	Vib Vzw	The use of a polypeptide domain of slpi to modulate the tumorigenic and metastatic potential of cancer cells
WO2006122404A1 (en) *	2005-05-16	2006-11-23	Her Majesty The Queen In Right As Represented By The Minister Of Health	Trappin-2 (elafin) inhibits hiv
US7964350B1 (en)	2007-05-18	2011-06-21	Applied Biosystems, Llc	Sample preparation for in situ nucleic acid analysis
WO2010071833A1 (en)	2008-12-19	2010-06-24	Life Technologies Corporation	Proteinase k inhibitors, methods and compositions therefor
GB201003559D0 (en) *	2010-03-03	2010-04-21	Proteo Biotech Ag	Novel use of elafin
WO2023122590A1 (en) *	2021-12-20	2023-06-29	Tiakis Biotech Ag	Use of elafin in the treatment of covid-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4746729A (en) *	1986-07-30	1988-05-24	Kuettner Klaus E	Cartilage-derived leukocyte elastase-inhibitor
US6024983A (en) *	1986-10-24	2000-02-15	Southern Research Institute	Composition for delivering bioactive agents for immune response and its preparation
AU5192790A (en) *	1989-02-23	1990-09-26	Center For Blood Research, The	Human elastase inhibitor
NO177716C (no) *	1989-06-09	1995-11-08	Zeneca Ltd	Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff

1990
- 1990-06-01 NO NO902444A patent/NO177716C/no not_active IP Right Cessation
- 1990-06-03 IL IL9460290A patent/IL94602A/en active IP Right Grant
- 1990-06-04 DE DE69024104T patent/DE69024104T2/de not_active Expired - Lifetime
- 1990-06-04 ES ES90306037T patent/ES2080800T3/es not_active Expired - Lifetime
- 1990-06-04 DK DK90306037.4T patent/DK0402068T3/da active
- 1990-06-04 AT AT90306037T patent/ATE131493T1/de not_active IP Right Cessation
- 1990-06-04 EP EP90306037A patent/EP0402068B1/en not_active Expired - Lifetime
- 1990-06-05 IE IE200690A patent/IE70520B1/en not_active IP Right Cessation
- 1990-06-05 AU AU56808/90A patent/AU636148B2/en not_active Expired
- 1990-06-07 NZ NZ233974A patent/NZ233974A/xx unknown
- 1990-06-08 CA CA002018592A patent/CA2018592C/en not_active Expired - Lifetime
- 1990-06-08 FI FI902880A patent/FI106471B/fi active IP Right Grant
- 1990-06-08 JP JP2148816A patent/JP2989853B2/ja not_active Expired - Lifetime
- 1990-06-08 PT PT94326A patent/PT94326B/pt not_active IP Right Cessation
1992
- 1992-08-10 US US07/926,371 patent/US5464822A/en not_active Expired - Lifetime
1995
- 1995-04-24 US US08/427,170 patent/US6245739B1/en not_active Expired - Fee Related
- 1995-12-14 GR GR940404015T patent/GR3018401T3/el unknown
2001
- 2001-04-13 US US09/833,799 patent/US6893843B2/en not_active Expired - Fee Related
2005
- 2005-03-21 US US11/084,860 patent/US20060068480A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US6245739B1 (en)	2001-06-12
JP2989853B2 (ja)	1999-12-13
DE69024104T2 (de)	1996-06-13
NO177716C (no)	1995-11-08
NZ233974A (en)	1993-05-26
NO902444D0 (no)	1990-06-01
JPH03148299A (ja)	1991-06-25
IE902006L (en)	1990-12-09
EP0402068A1 (en)	1990-12-12
US20020187535A1 (en)	2002-12-12
CA2018592A1 (en)	1990-12-09
PT94326A (pt)	1991-02-08
US6893843B2 (en)	2005-05-17
AU5680890A (en)	1990-12-13
PT94326B (pt)	1997-01-31
US5464822A (en)	1995-11-07
DK0402068T3 (da)	1996-04-22
ES2080800T3 (es)	1996-02-16
ATE131493T1 (de)	1995-12-15
EP0402068B1 (en)	1995-12-13
DE69024104D1 (de)	1996-01-25
FI106471B (fi)	2001-02-15
AU636148B2 (en)	1993-04-22
CA2018592C (en)	2002-08-27
NO177716B (no)	1995-07-31
IL94602A (en)	1996-06-18
US20060068480A1 (en)	2006-03-30
NO902444L (no)	1990-12-10
IE70520B1 (en)	1996-12-11
IL94602A0 (en)	1991-04-15
GR3018401T3 (en)	1996-03-31

Publication	Publication Date	Title
FI902880A0 (fi)	1990-06-08	Polypeptider och polypeptidanaloger.
ATE152172T1 (de)	1997-05-15	Herstellung eines rekombinanten menschlichen interleukin-1-hemmers
DE59004262D1 (de)	1994-03-03	Mehrzweck-Saugdüse.
FI873162A0 (fi)	1987-07-17	Foerfarande foer framstaellning av proteiner med faktor viii aktivitet med mikrobiala vaerdceller; expressionsvektorer, vaerdceller och antikroppar.
AU2308992A (en)	1993-02-11	Cysteine depleted il-6 muteins
DE68917837D1 (de)	1994-10-06	Peptid-Verbindungen.
DE68908958D1 (de)	1993-10-14	Peptide.
CA2118498A1 (en)	1993-11-11	A novel anti-neoplastic cytokine
ATE81591T1 (de)	1992-11-15	Interleukin-2 induziertes antineoplastisches peptid.
AU7052291A (en)	1991-07-18	Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus
NO893283L (no)	1991-02-18	Engangssproeyte med innebygget kanyle.
IT8821282A0 (it)	1988-07-08	Clonaggio del gene che codifica l'enzima isoamilasi e suo impiego per la produzione di detto enzima o suoi analoghi.
IT8821123A0 (it)	1988-06-28	Clonaggio del gene che codifica l'enzima isoamilasi e suo impiego per la produzione di detto enzima o suoi analoghi.
CA2090121A1 (en)	1992-02-24	Uses of colony stimulating factor-1
MX9203400A (es)	1992-07-01	Tratamiento de la disfuncion de leucocitos con gm-csf.

Legal Events

Date	Code	Title	Description
1994-03-23	GB	Transfer or assigment of application	Owner name: ZENECA LIMITED
2004-08-31	FG	Patent granted	Owner name: WIEDOW, OLIVER